Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization.
Zoledronic acid (ZA) exerts complex influence on bone by suppressing bone resorption, mostly due to the direct osteoclasts inhibition and uncertain influence on osteoblasts. Vitamin K2 (VK2, Menaquinone-4) as an anabolic agent stimulates bone formation via anti-apoptosis in osteoblasts and mild oste...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC6101397?pdf=render |
| _version_ | 1819077795752443904 |
|---|---|
| author | Bin Zhao Wenqian Zhao Yiqiang Wang Zhao Zhao Changfeng Zhao Shue Wang Chunzheng Gao |
| author_facet | Bin Zhao Wenqian Zhao Yiqiang Wang Zhao Zhao Changfeng Zhao Shue Wang Chunzheng Gao |
| author_sort | Bin Zhao |
| collection | DOAJ |
| description | Zoledronic acid (ZA) exerts complex influence on bone by suppressing bone resorption, mostly due to the direct osteoclasts inhibition and uncertain influence on osteoblasts. Vitamin K2 (VK2, Menaquinone-4) as an anabolic agent stimulates bone formation via anti-apoptosis in osteoblasts and mild osteoclasts inhibition. Based on these knowledge, the therapeutic effect of the combined or sequential therapy of VK2 and ZA depends on the influence on the osteoblasts, since both cases exert similar inhibitory effect on osteoclasts. In a series of in vitro studies, we confirmed the protective effect of VK2 in osteoblasts culture, especially when followed by exposure to ZA, and the proliferation and mineralization inhibition induced by ZA towards osteoblasts. For mechanism study, expression of bcl-2/bax, Runx2 and Sost in cells were examined. For in vivo studies, an osteoporosis animal model was established in rats via ovariectomy (OVX) and subjected to sequential treatment, namely VK2 followed by ZA. Bone mineral density (BMD) was measured by Dual energy X-ray absorptionmetry (DEXA), morphology and mechanical parameters by micro-computed tomography (micro-CT), mechanical strength by an electro-hydraulic fatigue-testing machine. The bone calcium, hydroxyproline content, blood lipids were evaluated using microplate technique, and the bone surface turnover was evaluated using the fluorescence in corporation method. It was found that VK2 pretreatment partially prevented the inhibition of bone formation caused by ZA, which was reflected by indices like BMD, bone calcium content and bone strength. The underling mechanisms for protection of VK2 pretreatment, mainly demonstrated via in vitro studies, included inhibiting apoptosis and depressing Sost expression in osteoblasts, which in turn improved the osteoporosis therapeutic effects of ZA. These findings suggested that pretreatment with VK2 before ZA therapy might serve a new long-term therapy protocol for osteoporosis. |
| first_indexed | 2024-12-21T19:02:53Z |
| format | Article |
| id | doaj.art-5bb975ee645d40f7af3e2c13bd45b1ed |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T19:02:53Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-5bb975ee645d40f7af3e2c13bd45b1ed2022-12-21T18:53:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020226910.1371/journal.pone.0202269Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization.Bin ZhaoWenqian ZhaoYiqiang WangZhao ZhaoChangfeng ZhaoShue WangChunzheng GaoZoledronic acid (ZA) exerts complex influence on bone by suppressing bone resorption, mostly due to the direct osteoclasts inhibition and uncertain influence on osteoblasts. Vitamin K2 (VK2, Menaquinone-4) as an anabolic agent stimulates bone formation via anti-apoptosis in osteoblasts and mild osteoclasts inhibition. Based on these knowledge, the therapeutic effect of the combined or sequential therapy of VK2 and ZA depends on the influence on the osteoblasts, since both cases exert similar inhibitory effect on osteoclasts. In a series of in vitro studies, we confirmed the protective effect of VK2 in osteoblasts culture, especially when followed by exposure to ZA, and the proliferation and mineralization inhibition induced by ZA towards osteoblasts. For mechanism study, expression of bcl-2/bax, Runx2 and Sost in cells were examined. For in vivo studies, an osteoporosis animal model was established in rats via ovariectomy (OVX) and subjected to sequential treatment, namely VK2 followed by ZA. Bone mineral density (BMD) was measured by Dual energy X-ray absorptionmetry (DEXA), morphology and mechanical parameters by micro-computed tomography (micro-CT), mechanical strength by an electro-hydraulic fatigue-testing machine. The bone calcium, hydroxyproline content, blood lipids were evaluated using microplate technique, and the bone surface turnover was evaluated using the fluorescence in corporation method. It was found that VK2 pretreatment partially prevented the inhibition of bone formation caused by ZA, which was reflected by indices like BMD, bone calcium content and bone strength. The underling mechanisms for protection of VK2 pretreatment, mainly demonstrated via in vitro studies, included inhibiting apoptosis and depressing Sost expression in osteoblasts, which in turn improved the osteoporosis therapeutic effects of ZA. These findings suggested that pretreatment with VK2 before ZA therapy might serve a new long-term therapy protocol for osteoporosis.http://europepmc.org/articles/PMC6101397?pdf=render |
| spellingShingle | Bin Zhao Wenqian Zhao Yiqiang Wang Zhao Zhao Changfeng Zhao Shue Wang Chunzheng Gao Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization. PLoS ONE |
| title | Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization. |
| title_full | Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization. |
| title_fullStr | Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization. |
| title_full_unstemmed | Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization. |
| title_short | Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization. |
| title_sort | prior administration of vitamin k2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid induced inhibition of osteoblasts proliferation and mineralization |
| url | http://europepmc.org/articles/PMC6101397?pdf=render |
| work_keys_str_mv | AT binzhao prioradministrationofvitamink2improvesthetherapeuticeffectsofzoledronicacidinovariectomizedratsbyantagonizingzoledronicacidinducedinhibitionofosteoblastsproliferationandmineralization AT wenqianzhao prioradministrationofvitamink2improvesthetherapeuticeffectsofzoledronicacidinovariectomizedratsbyantagonizingzoledronicacidinducedinhibitionofosteoblastsproliferationandmineralization AT yiqiangwang prioradministrationofvitamink2improvesthetherapeuticeffectsofzoledronicacidinovariectomizedratsbyantagonizingzoledronicacidinducedinhibitionofosteoblastsproliferationandmineralization AT zhaozhao prioradministrationofvitamink2improvesthetherapeuticeffectsofzoledronicacidinovariectomizedratsbyantagonizingzoledronicacidinducedinhibitionofosteoblastsproliferationandmineralization AT changfengzhao prioradministrationofvitamink2improvesthetherapeuticeffectsofzoledronicacidinovariectomizedratsbyantagonizingzoledronicacidinducedinhibitionofosteoblastsproliferationandmineralization AT shuewang prioradministrationofvitamink2improvesthetherapeuticeffectsofzoledronicacidinovariectomizedratsbyantagonizingzoledronicacidinducedinhibitionofosteoblastsproliferationandmineralization AT chunzhenggao prioradministrationofvitamink2improvesthetherapeuticeffectsofzoledronicacidinovariectomizedratsbyantagonizingzoledronicacidinducedinhibitionofosteoblastsproliferationandmineralization |